Insider Trading & SAST disclosures for Zenotech Laboratories Ltd.
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
SUN PHARMACEUTICAL INDUSTRIES LIMITED in Zenotech Laboratories Ltd. where Acquisition of 6,886,500
Equity Shares done at an average price of Rs. 7.7
was reported to the exchange on March 31, 2022.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Daiichi Sankyo Company Ltd in Zenotech Laboratories Ltd. where Disposal of 6,886,500
shares done
was reported to the exchange on March 29, 2022.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
SUN PHARMACEUTICAL INDUSTRIES LIMITED
|
Promoter |
Acquisition |
31 Mar 2022 |
6,886,500 |
42,014,578
(68.84%)
|
11.28%
|
7.7 |
53,232,645
|
29 Mar 2022
29 Mar 2022 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
|
DAIICHI SANKYO COMPANY LIMITED
|
Promoter Group |
Disposal |
29 Mar 2022 |
6,886,500 |
0
(0%)
|
11.28%
|
7.7 |
53,232,645
|
29 Mar 2022
29 Mar 2022 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
|
Daiichi Sankyo Company Ltd
|
Promoter |
Disposal |
30 Mar 2022 |
6,886,500 |
-
|
11.28%
|
|
-
|
29 Mar 2022
29 Mar 2022 |
SAST (29(2)) |
- |
Off Market / Inter se transfer |
|
Sun Pharmaceutical Industries Ltd
|
Promoter |
Acquisition |
30 Mar 2022 |
6,886,500 |
42,014,578
(68.84%)
|
11.28%
|
|
-
|
29 Mar 2022
29 Mar 2022 |
SAST (29(2)) |
- |
Off Market / Inter se transfer |
|
Sun Pharmaceutical Industries Ltd
|
Other |
Acquisition |
01 Apr 2022 |
6,886,500 |
-
|
11.28%
|
|
-
|
29 Mar 2022
29 Mar 2022 |
SAST (10(6)) |
- |
- |
|
Sun Pharmaceutical Industries Ltd
|
Promoter |
Acquisition |
24 Mar 2022 |
6,886,500 |
-
|
11.28%
|
|
-
|
26 Mar 2022
26 Mar 2022 |
SAST (10(1)(a)) |
- |
None |
|
Sun Pharmaceuticals Industries Ltd
|
Promoter |
Acquisition |
31 Jul 2017 |
19,000,000 |
35,128,078
(57.56%)
|
31.13%
|
|
-
|
27 Jul 2017
27 Jul 2017 |
SAST (29(2)) |
- |
Rights Issue |
|
Hardik B Patel & Ruchit B Patel
|
Other |
Acquisition |
31 Jul 2017 |
3,639,966 |
3,642,966
(5.97%)
|
5.96%
|
|
-
|
28 Jul 2017
28 Jul 2017 |
SAST (29(1)) |
- |
Rights Issue |
|
Sun Pharmaceutical Industries Ltd
|
Promoter |
Acquisition |
29 Jul 2017 |
19,000,000 |
35,128,078
(57.56%)
|
31.13%
|
45 |
855,000,000
|
26 Jul 2017
26 Jul 2017 |
Insider Trading |
Equity Shares |
Rights Issue |
|
Sun Pharmacetical
|
Promoter |
Acquisition |
27 Mar 2015 |
16,127,293 |
16,127,293
(46.84%)
|
46.84%
|
|
-
|
24 Mar 2015
24 Mar 2015 |
SAST (29(1)) |
- |
Scheme Of Arrangement (merger) |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.